MetaCap

SpyGlass Pharma Inc. (SGP)

NASDAQ: SGPHealth CareMedical/Dental InstrumentsUSD

30.43-0.35 (-1.14%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SGP stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$2.70
52-week range
17.06 – 39.92
Day range
29.60 – 31.73
Volume / Avg
108.91K / 114.63K
Beta
—

52-week range

$17.06$39.92

SGP stock today

On Nov 20, SGP ended the session at $30.43, shedding $0.35 (1.14%), versus the S&P 500's 3.70% decline. At this level, SGP sits in the middle of its 52-week range of $17.06 to $39.92: 23.8% below the high, set on Nov 9, 2026 and 78.4% above the low. SpyGlass Pharma has posted a net loss over the last twelve months (EPS of -$2.70), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About SpyGlass Pharma

Company profile

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients.

Industry
Medical/Dental Instruments
CEO
Mr. Patrick H. Mooney
Headquarters
Irvine, CA
Employees
88
IPO year
2026

Financial highlights

Full financials

SpyGlass Pharma reported a net loss of $39.9 million, compared with a loss of $29.2 million a year earlier. Diluted earnings per share came in at -$17.98.

SpyGlass Pharma annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024
Revenue——
Growth——
Net income$-39.87M$-29.16M
EPS (diluted)$-17.98$-16.31

Analyst forecast

Forecast

Consensus (6 analysts)

strong_buy

Avg. price target

$46.67+53.37%

  • Strong buy 1
  • Buy 5
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $42.00High $62.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 11, 2026
EPS actual vs est.
$-0.73 vs $-0.66
Surprise
-10.61%

SGP news

All SGP news

SpyGlass Pharma peers

Health Care sector
SGP peer companies
CompanyPrice% ChgMarket capCompare
IARTIntegra LifeSciences Holdings Corporation13.25-2.21%$1.03Bvs SGP
ATECAlphatec Holdings Inc.6.68-3.19%$1.02Bvs SGP
IRMDiRadimed Corporation81.02-0.30%$1.04Bvs SGP
SIBNSI-BONE Inc.23.73-0.08%$1.07Bvs SGP
DRTSAlpha Tau Medical Ltd.11.76+3.93%$1.09Bvs SGP
AORTArtivion Inc.18.16-2.00%$886.02Mvs SGP
TNDMTandem Diabetes Care Inc.17.46+3.93%$1.22Bvs SGP
KIDSOrthoPediatrics Corp.31.74-2.37%$828.75Mvs SGP

Indexes, lists and sector

SpyGlass Pharma stock FAQ

What is SpyGlass Pharma's stock price today?

SGP last traded at $30.43 as of Nov 20, 4:00 PM EST, down 1.14% on the day. Prices are delayed at least 15 minutes.

Who is SpyGlass Pharma's CEO?

Mr. Patrick H. Mooney is the chief executive officer of SpyGlass Pharma Inc., which has about 88 employees.

What is the SGP 52-week high?

The 52-week high for SGP is $39.92 and the 52-week low is $17.06. The stock is currently 23.8% below its high.

Compare SGP